History of the Former Fujisawa Pharmaceutical Co., Ltd.

Tomokichi Fujisawa founded Fujisawa Shoten in Osaka

Launched "Fujisawa Camphor" as a home-use insect repellent

Changed the company name to Fujisawa Pharmaceutical Co., Ltd.

Central Laboratory completed

Launched "Cefamezin," an antibiotic for injections
Proceeds to market it worldwide.

Established Fujisawa Pharmaceutical Corp. in the U.S.
The company's first business base in the U.S.

Opened a London Office, the company's first business base in Europe

Tsukuba Laboratory completed

Established Fujisawa Europe GmbH in Germany

Launched immunosuppressant "Prograf"
Currently sold in about 100 countries

Restructured the business in the U.S., founds Fujisawa Healthcare, Inc.

Launched "Protopic," an agent to treat atopic dermatitis
Currently sold in about 60 countries

OTC businesses of both companies were integrated in October 1, 2004 to form Zepharma Inc.